Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2020 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1

  • Authors:
    • Jingwen Wu
    • Wen Ren
    • Zhichao Zheng
    • Zhu Huang
    • Tingting Liang
    • Fuyao Li
    • Zhan Shi
    • Qianzhou Jiang
    • Xuechao Yang
    • Lvhua Guo
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China, Faculty of Arts and Science, Human Biology Program, University of Toronto, Toronto, Ontario M5S 1A1, Canada
    Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1737-1746
    |
    Published online on: June 22, 2020
       https://doi.org/10.3892/mmr.2020.11264
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Circular RNAs (circRNAs) are a class of non‑coding RNAs that exhibit important regulatory roles in various biological processes. However, the role of circRNAs and their potential role in osteoblast differentiation and mineralization is unclear. The aim of the present study was to investigate the expression of mmu_circ_003795 and its effect on collagen type XV α 1 chain (COL15A1). First, it was identified that the expression levels of mmu_circ_003795 and osteopontin (OPN) were upregulated in the induced cells. Silencing of mmu_circ_003795 reduced the gene and protein levels of COL15A1 and OPN, whereas the expression level of mmu‑microRNA (miR)‑1249‑5p was upregulated. In addition, after 7 or 14 days of induction, alkaline phosphatase and Alizarin Red‑S staining were decreased in the mmu_circRNA_003795 inhibitory group compared with the negative control group. In conclusion, mmu_circ_003795 may regulate osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 cells via mmu‑miR‑1249‑5p by targeting COL15A1.

Introduction

Non-healing bone defects due to trauma, infection and tumor ablation restrict the development of oral implant restoration (1). Therefore, identifying ways to accelerate bone integration has become an urgent requirement. Due to their strong osteogenesis, ease of culture and availability, MC3T3-E1 and MDPC23 cells are considered good candidates for alveolar bone regeneration. Osteogenesis is a complex process that is strictly regulated by numerous pathways (2). The molecular mechanism of osteogenesis and mineralization remains unclear.

Circular RNAs (circRNAs) are a new class of non-coding RNAs that serve important roles in multiple biological processes (3,4). Due to advances in science and technology, particularly in bioinformatics and RNA sequencing technologies, it has been determined that numerous exon transcripts can be used to form circRNAs by nonlinear reverse splicing or gene rearrangement. circRNA molecules that exhibit a closed ring structure are thought to serve an important role in bone metabolism (5,6). For example, osteogenesis can be enhanced by mm9_circ_009056, which upregulates bone morphogenetic protein 7 by targeting microRNA (miR/miRNA)-22-3p (7). Additionally, the circRNA CDR1-AS can activate Smad1/5/8 and p38 mitogen associated protein kinase pathways to promote osteogenesis of periodontal ligament stem cells by inhibiting miR-7 expression (8). Therefore, the present study attempted to explain the molecular mechanism of osteogenesis and mineralization via circRNAs.

The authors' previous study found that mmu_circ_003795 was significantly upregulated in bone marrow-derived stem cells (BMSCs) undergoing cell proliferation, demonstrating that mmu_circ_003795 may serve an important role in the proliferation of BMSCs (9). The present study further investigated the function of mmu_circ_003795 in the osteogenesis of MC3T3-E1 and MDPC23 cells.

Materials and methods

Cell culture

MC3T3-E1 (American Type Culture Collection) and MDPC23 (Cellcook) cells were plated on 6-well plate culture dishes at density of 1×105 cells/well. In addition, 2 ml Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc.) containing 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) was added to each well. Cells were maintained in a humidified atmosphere of 95% air and 5% CO2 at 37°C.

Transfection of small interfering RNAs (siRNAs), mimics and inhibitors

The siRNAs, mimics and inhibitors were designed and synthesized by Guangzhou RiboBio Co., Ltd. (siRNA: Sense: 5′-GCUAGAACAGCAUGGUCCAdTdT-3′, antisense: 3′-dTdTCGAUCUUGUCGUACCAGGU-5′; inhibitors: 5′-UCCUCCCUCCCCUACCCGGUUCAAG-3′; mimic sense: 5′-AGGAGGGAGGGGAUGGGCCAAGUUC-3′, antisense: 5′-UCCUCCCUCCCCUACCCGGUUCAAG-3′) (Table I). MC3T3-E1 and MDPC23 cells were seeded in 6-well plates at a density of 1×105/well. The cells were transfected with 20 nM siRNA mimics or inhibitors using GenMute™ siRNA Transfection kit and Transfection Buffer (SignaGen Laboratories) according to the manufacturer's protocol. To ensure a high silencing efficiency, the transfection medium with siRNAs was changed every 72 h. Experiments were performed 24–72 h post transfection.

Table I.

The primers of the detected genes.

Table I.

The primers of the detected genes.

NamePrimer
COL15A1F: 5′-CTCGCGGGTTACATAAGGCT-3′
R: 5′-GTAGAGGATAACCCGCTGGC-3′
ALPF: 5′-GAGGCATACGCCATCACATG-3′
R: 5′-CCGATGGCACACCTGCTT-3′
OCNF: 5′-TCTGACAAAGCCTTCATGTCCA-3′
R: 5′-AACGGTGGTGCCATAGAT-3′
GAPDHF: 5′-AAGAAGGTGGTGAAGCAGG-3′
R: 5′-GAAGGTGGAAGAGTGGGAG-3′
OSXF: 5′-GCAAATGACTACCCACCCTT-3′
R: 5′-ACGAGCCATAGGGATGAGTC-3′
RUNX2F: 5′-ACTTGTGGCTGTTGTGATG-3′
R: 5′-TTGCTGTTGCTGTTGTTG-3′
mmu_circRNA_003795F: 5′-CCTTAGCACCTGCCTTCTTG-3′
R: 5′-AGTTCACCCACTGTGCCTCC-3′
mmu-miR-1249-5p 5′-AGGAGGGAGGGGATGGGCCAAGTTC-3′
U6 5′-GCGCGTCGTGAAGCGTTC-3′
Inhibitor-miR-1249-5p 5′-UCCUCCCUCCCCUACCCGGUUCAAG-3′
Mimic-miR-1249-5pF: 5′-AGGAGGGAGGGGAUGGGCCAAGUUC-3′
R: 5′-UCCUCCCUCCCCUACCCGGUUCAAG-3′

[i] miR, microRNA; ALP, alkaline phosphatase; OCN, osteocalcin; RUNX2, runt-related transcription factor 2; OSX, Sp7 transcription factor; COL15A1, collagen type XV α 1 chain; OPN, osteopontin; circ, circular; F, forward; R, reverse.

Microarray hybridization

The MDPC23 cells were divided into two groups and treated as before. In the subject group, 1×105 cells were treated with the induction medium containing 20 nM siRNA of mmu_circ_003795 for 7 days. In the control groups, the cells (1×105) were treated with the induction medium containing 20 nM negative control siRNA for 7 days. The sequences of siRNA were as follows: (Sense 5′-GCUAGAACAGCAUGGUCCAdTdT-3′ and antisense 3′-dTdTCGAUCUUGUCGUACCAGGU-5′). These two groups were used to detect the expression of mRNAs and miRNAs following silencing of mmu_circRNA_003795. Total RNA from each sample was quantified using the NanoDrop ND-2000 (Thermo Fisher Scientific, Inc.). The sample preparation and microarray hybridization were performed based on the standard protocols of the BGI group (10).

Detection of alkaline phosphatase (ALP) activity

Cells were seeded into 48-well plates at a density of 5×103 cells/well. The MDPC23 and MC3T3-E1 cells were divided into two groups: The control group and the subject group. In the subject group, the cells (5×103) were treated with the induction medium containing 20 nm siRNA of mmu_circ_003795 for 14 days. In the control group, the cells (5×103) were treated with the induction medium containing 20 nM negative control siRNA for 14 days. The medium was changed every 3 days. An Alkaline Phosphatase Staining Kit (BestBio, Inc.) was used to detect the ALP activity, according to the manufacturer's protocol.

Alizarin Red-S (ARS) staining

Mineralization in MC3T3-E1 and MDPC23 cells was measured by staining with ARS. Cells were seeded in 48-well plates at a density of 5×103 cells/well. As previously the MDPC23 and MC3T3-E1 cells were divided into two groups. In the subject group, the cells were treated with the induction medium containing 20 nm siRNA of mmu_circ_003795. In the control group, the cells were treated with the induction medium containing 20 nM negative control siRNA. The medium was changed every 3 days. Following culture for 21 days, cells were fixed with 4% paraformaldehyde for 10 min after washing three times with PBS at room temperature. Subsequently, the ARS solution (BestBio, Inc.) was used to stain the cells at 37°C for 30 min. The stained cells were observed by a stereo light microscope (Leica Microsystems GmbH). For quantification analysis, 10% hexadecyl pyridinium chloride monohydrate (CPC; Sigma-Aldrich; Merck KGaA) was used to dissolve the mineralized nodules and then the absorbance was measured at 562 nm using a Multiskan™ FC spectrophotometer (Thermo Fisher Scientific, Inc.).

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and nucleic acid electrophoresis

The total RNA of BMSCs was extracted using TRIzol reagent (Thermo Fisher Scientific, Inc.). The quantity and quality of RNA were determined using a NanoDrop 2000. Following RNA extraction, SuperScript III reverse transcriptase (Invitrogen; Thermo Fisher Scientific, Inc.) was used to synthesize complementary DNA (cDNA), according to the manufacturer's protocol. In the reverse transcription reaction the temperature protocol was as follows: 65°C for 5 min and 4°C for 1 min in the first step, followed by 37°C for 1 min, 50°C for 60 min and 70°C for 15 min in the second step. Subsequently, qPCR was performed using 12.5 µl SYBR Premix EX Taq (Takara Bio, Inc.), 0.5 µl forward primer (10 pmol/l), 0.5 µl reverse primer (10 pmol/l;), 1 µl cDNA and ddH2O to create a final volume of 25 µl. The primers used are listed in Table I. The reaction conditions were as follows: 95°C for 30 sec; and 95°C for 5 sec, 55°C for 30 sec and 72°C for 30 sec for 40 cycles. The instrument automatically generated the cycle quantification (Cq) value of mRNA and the internal reference gene GAPDH. Cq value difference (ΔCq) indicated the relative expression of each mRNA investigated (11).

Identification of differentially expressed mRNAs

Quantile normalization of the original data and subsequent data processing was performed using the R software package (version 3.1.2) (12). After quantile normalization of the original data was performed, low-intensity filtering was carried out and the mRNAs with P (present) or M (marginal) (‘all target values’) tagged in at least one or two samples were retained for further analysis. When comparing the two sets of contours, the ‘fold-change’ (namely, the ratio of the group mean) between groups of mRNAs was calculated. The statistical significance of the differences between groups was determined using a t-test. mRNAs exhibiting a significant difference in expression exhibited a fold-change >2 and P<0.05. The sorting and filtering function of Microsoft Excel 2019 (Microsoft Corporation) was used to filter data, analyze output and sort the mRNAs with differential expression according to the fold-changes and P-values. In addition, gene ontology (GO) analysis was performed to classify the related mRNAs (13). miRDB (http://www.mirdb.org/), TargetScan (http://www.targetscan.org/) and mirbases (http://www.mirbase.org/) were used to determine the corresponding target genes. All differentially expressed miRNAs were annotated in detail with information on the interaction between mmu_circ_003795 and miRNAs. Cytoscape (version 3.6.0; http://cytoscape.org) software was used to generate a network map.

Western blotting

Radioimmunoprecipitation assay buffer [50 mM Tris HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P40 and 0.1% sodium dodecyl sulfate] and phenylmethanesulfonyl fluoride were used at 4°C to extract protein from the cells according to the standard procedure. The concentration was determined using a bicinchoninic acid protein assay kit (BestBio, Inc.). Total protein (10 µg/well) was separated using 10% SDS-PAGE and then transferred to a polyvinylidene difluoride membrane. Skimmed milk was used to block membranes for 1 h at room temperature, then the blots were incubated with primary antibodies against OPN (1:1,000; catalog no. ab124830; Abcam), COL15A1 (1:1,000; catalog no. PA5-69518; Thermo Fisher Scientific, Inc.) and β-actin (1:5,000; catalog no. ab8226; Abcam) overnight at 4°C. Following washing with 0.1% Tween PBS-T, the blots were incubated with goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1:5,000; catalog no. ab6799; Abcam) for 1 h at room temperature. An enhanced chemiluminescent (ECL) kit (Beijing Dingguo Changsheng Biotechnology Co., Ltd.) was used to detect the proteins. ImageJ (version k1.45; National Institutes of Health) was used to measure densitometry.

Statistical analysis

All data were analyzed using the SPSS 11.5 software package (SPSS, Inc.). The data were expressed as the mean ± standard deviation and the comparison of the data between groups was performed using paired t-test or two-way analysis of variance according to the nature of the data. Each experiment was repeated three times. The data of three groups were evaluated using analysis of variance and followed by Fisher's least significant difference post hoc test when the variance was normal, otherwise Dunnett's T3 test was used. P<0.05 was considered to indicate a statistically significant difference.

Results

mmu_circ_003795 is upregulated during osteoblast differentiation of MC3T3-E1 and MDPC23 cells

MC3T3-E1 and MDPC23 cells were cultured with induction medium for 3 days. RT-qPCR was used to analyze the expression levels of mmu_circRNA_003795 and the osteogenic marker OPN, ALP, Sp7 transcription factor (OSX), osteocalcin (OCN) and runt-related transcription factor 2 (RUNX2). The results demonstrated that mmu_circRNA_003795, OPN, ALP, OSX, OCN and RUNX2 were increased (Fig. 1A). The ALP and ARS staining were performed to verify the successful induction (Fig. 1B and C). An siRNA sequence was designed to silence mmu_circRNA_003795. MDPC23 cells were transfected with negative control RNAs or siRNAs for 7 days. In the miRNA microarray, 1,729 miRNAs were different between the control and subject groups (Fig. 2A). The present study identified that mmu_circRNA_003795 is most likely bound to mmu-miR-1249-5p, mmu-miR-504-3p, mmu-miR-6399, mmu-miR-7054-5p and mmu-miR-667-5p (Fig. 2B). By comparing the aforementioned data, the present study selected mmu-miR-1249-5p as the target miRNA. The seed sequences of the circRNA were compared with miRNA sequences to identify the miRNAs that potentially bind to circRNAs (Fig. 2C).

Figure 1.

Expression of mmu_circRNA_003795 and OPN in MC3T3-E1 and MDPC23 cells. (A) Reverse transcription-quantitative PCR analysis of mmu_circRNA_003795 and OPN in MC3T3-E1 and MDPC23 cells following osteogenic induction. (B) The ALP assay of MC3T3-E1 and MDPC23 cells 10 days after induction. (C and D) The ARS assay of MC3T3-E1 and MDPC23 cells 21 days after induction. ***P<0.005 vs. the control. ALP, alkaline phosphatase; ARS, Alizarin Red-S; OPN, osteopontin; RUNX2, runt-related transcription factor 2; OSX, Sp7 transcription factor; circ, circular; OCN, osteocalcin.

Figure 2.

Microarray hybridization analysis (A) Cytoscape software was used to create a network map of mmu_circRNA_003795 with miRNAs that exhibited differential expression. (B) Cytoscape software was used to create a network map of mmu_circRNA_003795 with target miRNAs. (C) Potential binding sites of mmu_circRNA_003795 and miR-1249-5p were predicted using bioinformatics tools. (D) Annotation of the parental genes of the differentially expressed mRNAs using GO analysis. GO, Gene Ontology; circRNA, circular RNA; OPN, osteopontin; miRs/miRNAs, microRNAs; UTR, untranslated region.

Identification of differentially expressed mRNAs

GO analysis was performed to classify the related mRNAs. The analysis focused on ‘Biological Process’, ‘Cellular Component’ and ‘Molecular Function’ terms that may be associated with osteogenesis differentiation. The top GO terms were ranked by number of genes (Fig. 2D). miRDB (http://www.mirdb.org/), TargetScan (http://www.targetscan.org/) and mirbases (http://www.mirbase.org/) were used to determine the corresponding target genes of miR1249-5p. The above data was compared with the current mRNA microarray data. According to the analysis, miR1249-5p and COL15A1 may have regulated osteoblast differentiation and mineralization in MDPC23 cells.

Alterations in the expression of miR1249-5p, COL15A1 and OPN following mmu_circRNA_003795 interference

siRNA was used to knockdown mmu_circRNA_003795 in MC3T3-E1 and MDPC23 cells. Compared with the negative control group, the expression of mmu_circRNA_003795 in the siRNA group was decreased in both MC3T3-E1 and MDPC23 cells (Fig. 3A and B). Following successful silencing of mmu_circRNA_003795, the expression of miR-1249-5p was increased both in MC3T3-E1 and MDPC23 cells (Fig. 3C and D). Compared with the negative control group, the expression of OPN was significantly decreased in the mRNA microarray. It is known that OPN is one of the early marker proteins involved in osteogenic differentiation (14). The present study speculates that OPN may be involved in regulating osteoblast differentiation and mineralization in MDPC23 cells. Therefore, the current study also tried to verify the changes in OPN when interfering with circ003795 and miR-1249-5p. The expression levels of COL15A1 and OPN were significantly decreased in both cell lines (Fig. 3E and F). Western blotting revealed the same result; the western blot analysis demonstrated that silencing of mmu_circRNA_003795 reduced the protein expression levels of COL15A1 and OPN (Fig. 3G and H).

Figure 3.

Changes of miR-1249-5p, COL15A1 and OPN expression following mmu_circRNA_003795 silencing. Expression of mmu_circRNA_003795 in the interference and NC groups, as analyzed by RT-qPCR in (A) MC3T3-E1 and (B) MDPC23 cells. Successful transfection and knockdown, and increased expression of miR-1249-5p in (C) MC3T3-E1 and (D) MDPC23 cells, and COL15A1 and OPN also in (E) MC3T3-E1 and (F) MDPC23 cells following mmu_circRNA_003795 silencing, as analyzed by RT-qPCR. Western blotting analysis of COL15A1 and OPN following mmu_circRNA_003795 silencing in (G) MC3T3-E1 and (H) MDPC23 cells. *P<0.05 and **P<0.01 vs. NC. circRNA, circular RNA; OPN, osteopontin; RT-qPCR, reverse transcription-quantitative PCR; miR, microRNA; COL15A1, collagen type XV α 1 chain; NC, negative control; SI, small inhibitor.

Alterations in the expression of COL15A1 and OPN following miR1249-5p interference

An inhibitor and mimic were used to knockdown and overexpress miR1249-5p, respectively, in MC3T3-E1 and MDPC23 cells. Compared with the negative control group, the expression of miR1249-5p was decreased in the inhibitor group and increased in the mimic group in both MC3T3-E1 and MDPC23 cells (Fig. 4A and B). Following successful knockdown of miR1249-5p, the expression levels of COL15A1 and OPN were increased in MC3T3-E1 cells, whereas the expression levels of COL15A1 and OPN were decreased when miR1249-5p was overexpressed (Fig. 4C). This result was also demonstrated in MDPC23 cells (Fig. 4D). Western blotting revealed the same result. When miR1249-5p was upregulated or downregulated, the protein expression levels of COL15A1 and OPN were downregulated and upregulated, respectively (Fig. 4E and F). Compared with the negative control group, the staining and activity of ALP in the mmu_circRNA_003795 inhibition group was significantly reduced at 7 days (Fig. 5A). In addition, the ARS staining at 21 days revealed the same result. Following osteogenic induction for 21 days, the intensity of ARS staining in the mmu_circRNA_003795 inhibition group was significantly reduced. Compared with the negative control group, the matrix mineralization of the mmu_circRNA_003795 inhibition group was decreased (Fig. 5B and C).

Figure 4.

Silencing and overexpressing miR-1249-5p affects MC3T3-E1 and MDPC23 cells. RT-qPCR analysis of miR-1249-5p in MC3T3-E1 and MDPC23 cells following (A) silencing and (B) overexpressing miR-1249-5p. RT-qPCR analysis of COL15A1 and OPN in (C) MC3T3-E1 and (D) MDPC23 cells following silencing and overexpressing miR-1249-5p. Western blot analysis of COL15A1 and OPN following silencing and overexpressing miR-1249-5p in (E) MC3T3-E1 and (F) MDPC23 cells. *P<0.05, **P<0.01 and ***P<0.005. circRNA, circular RNA; OPN, osteopontin; RT-qPCR, reverse transcription-quantitative PCR; miR, microRNA; COL15A1, collagen type XV α 1 chain.

Figure 5.

Silencing of mmu_circ_003795 affects osteogenesis of MC3T3-E1 and MDPC23 cells. (A) ALP assay of MC3T3-E1 and MDPC23 cells 7 days after siRNA transfection. (B) ARS assay of MC3T3-E1 and MDPC23 cells 21 days after siRNA transfection. (C) Calcium nodules quantification assay. *P<0.05 and ***P<0.005. ARS, Alizarin Red-S; siRNA, small interfering RNA; miR, microRNA;circRNA, circular RNA; ALP, alkaline phosphatase, tissue nonspecific isozyme; OCN, osteocalcin; RUNX2, runt-related transcription factor 2; OSX, Sp7 transcription factor; COL15A1, collagen type XV α 1 chain; OPN, osteopontin; NC, negative control.

Discussion

circRNAs are circular RNA molecules that were first identified in the 1970s (15). Using electron microscopy, Hsu and Coca-Prados observed RNA could be a cyclic form in the cytoplasm of eukaryotic cells (16). With the continuous improvement of technology, circRNAs have become an increasingly important research area with huge development potential. circRNAs are now understood to exhibit structural stability, have conserved sequences and be extensively expressed in mammals (17,18). Additionally, circRNAs are tissue and time specific. MDPC23 cells are mouse odontoblast cells derived from the oral dentin of mice, while MC3T3-E1 cells are derived from the bone of mice. The tissue specificity of the two may explain the differences in the osteogenic mineralization ability when mmu_circRNA_003795 was inhibited. However, this needs to be further investigated in future experiments.

COL15A1, a novel marker in osteoblasts, is associated with important biological functions in osteogenic differentiation and mineralization. Lisignoli et al (19) identified that COL15A1 is differentially expressed between osteoblasts and MSCs that were isolated from the same donors using high throughput technology. Trošt et al (20) isolated primary cultures of osteoblasts from osteoporotic and non-osteoporotic human bone tissue samples. Using genome-wide gene expression sequencing, this previous study found COL15A1 was downregulated in osteoporotic bone tissue compared with non-osteoporotic human bone tissue. However, Gabusi et al reported that when chronically stimulated by Ca2+ at certain concentrations, the osteogenic ability of human osteoblasts was significantly enhanced, whereas the expression of COL15A1 was reduced (21).

OPN is a protein widely distributed in various tissues and cells, and it can participate in tissue repair, metabolism and other functions. OPN is associated with a variety of pathological processes, including cardiovascular disease, cancer, diabetes and kidney stones. OPN is also associated with physiological activities, such as cell viability, biomineralization and wound healing (22–25). OPN can regulate osteoclast function by influencing the expression levels of interleukin (IL)-10, IL-12 and IL-3 (26). Mineralized tissues, such as tooth and bones, release OPN that is generated by osteoclasts and osteoblasts. Additionally, OPN can enhance the adhesion of osteoblasts, osteoclasts and bone cells (27). In the mineralized collagen matrix during the formation of bone tissue, the adhesion of bone cells is upregulated through concentrating OPN (26,28). In the present study, MC3T3-E1 and MDPC23 cells were cultured in osteogenic induction medium containing siRNA. When the mineralization effect was tested by ALR staining after 21 days, compared with the control group, it was identified that the mineralized nodules in the 48-well plate were reduced, which may be due to the siRNA inhibiting the expression of COL15A1 and OPN, and ultimately affecting the cell adhesion and osteogenesis. Due to their strong osteogenesis, ease of culture and availability, MC3T3-E1 and MDPC23 cells are considered good candidates for alveolar bone regeneration (29,30). Therefore, it is important to understand the mechanism that regulates the differentiation of MDPC23 and MC3T3-E1 cells. circRNAs serve an important regulatory role in physiological activities (31). As a result of their abundant, stable and cell-specific expression, circRNAs are ideal biomarkers for the diagnosis of cancer, Alzheimer's disease, bone disease and other diseases (32–35). However, only a few studies have investigated the role of circRNAs during osteogenesis (36,37). Recently, the expression of circRNAs in the MC3T3-E1 cell line during osteogenic differentiation was studied (7). The present study suggested that mmu_circ_003795 regulates the osteoblast differentiation and mineralization in MC3T3-E1 and MDPC23 cells. The current study identified the mRNAs that are associated with the osteoblast differentiation and mineralization of MDPC23 cells.

The expression of corresponding parental genes can be increased by circRNAs through polymerase II elongation mechanism (17). Consequently, the present study investigated the regulatory role of mmu_circ_003795 by annotating the parental genes via GO analysis. The results revealed a large number of GO terms in the cellular processes and biological processes that were related to the osteogenic differentiation of cells. Previous studies have often focused on signaling proteins and osteogenic markers that play a key role in osteogenic differentiation (38,39). For example, ALP, OCN and calcium deposition have been largely studied (40). Whereas, only a few studies have evaluated the expression profile of circRNAs in osteoblastic differentiation (41,42). The present study suggested that mmu_circ_003795 may play an important role in the differentiation and mineralization of MC3T3-E1 and MDPC23 osteoblasts by targeting COL15A1. The mRNA expression levels of OPN and COL15A1 were decreased when siRNA was used to knockdown the expression of mmu_circRNA_003795. Therefore, the silencing of mmu_circRNA_003795 expression confirmed the association between mmu_circRNA_003795, mmu_miR_1249-5p, COL15A1 mRNA and OPN mRNA.

In conclusion, the preliminary observations of the present study demonstrated that mmu_circRNA_003795 can regulate osteoblast differentiation and mineralization in MC3T3-E1 and MDPC23 cells by targeting COL15A1 and OPN.

Acknowledgements

The authors would like to thank Dr Yan Yongyong (Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong, P.R. China) for his great help in writing this paper.

Funding

The present study was supported by the Science & Technology Bureau of Guangdong Province (grant nos. 2017A050501041 and 2018B050502012) and the National Key R&D Program of China (grant no. 2018YFB1106903).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

JW, WR, ZZ, ZH, TL, FL, ZS, QJ, LG and XY performed the experiments and analyzed the data. LG and ZZ designed the study and wrote the article. All authors approved the final submission.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Bianco P, Robey PG and Simmons PJ: Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Long T, Guo Z, Han L, Yuan X, Liu L, Jing W, Tian W, Zheng XH, Tang W and Long J: Differential expression profiles of circular RNAs during osteogenic differentiation of mouse adipose-derived stromal cells. Calcif Tissue Int. 103:338–352. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Deng T, Yang L, Zheng Z, Li Y, Ren W, Wu C and Guo L: Calcitonin gene-related peptide induces IL-6 expression in RAW264.7 macrophages mediated by mmu_circRNA_007893. Mol Med Rep. 16:9367–9374. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Zhang W, Dong R, Shu D, Du J, Fan Z and Wang F: Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res Ther. 8:302017. View Article : Google Scholar : PubMed/NCBI

6 

Li P, Chen S, Chen H, Mo X, Li T, Shao Y, Xiao B and Guo J: Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta. 444:132–136. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Wu C, Zheng Z, Ren W, Deng T, Li Y, Yang L, Wu J, Huang Z, Li Z and Guo L: Mm9_circ_009056 enhances osteogenesis by targeting BMP7 via CGRP-mediated miR-22-3p. Biochem Biophys Res Commun. 501:199–205. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Li X, Zheng Y, Zheng Y, Huang Y, Zhang Y, Jia L and Li W: Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway. Stem Cell Res Ther. 9:2322018. View Article : Google Scholar : PubMed/NCBI

9 

Ren W, Yang L, Deng T, Wu C, Li Y, Wu J, Huang Z, Du F and Guo L: Calcitonin gene related peptide regulates FOSL2 expression and cell proliferation of BMSCs via mmu_circRNA_003795. Mol Med Rep. 19:3732–3742. 2019.PubMed/NCBI

10 

Chen K, Liu J, Liu S, Xia M, Zhang X, Han D, Jiang Y, Wang C and Cao X: Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell. 170:492–506.e14. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

12 

R Core Team: R: A language and environment for statistical computing. Version 3.1.2. R foundation for statistical computing. (Vienna). 2014.PubMed/NCBI

13 

Grossmann S, Bauer S, Robinson PN and Vingron M: Improved detection of overrepresentation of gene-ontology annotations with parent child analysis. Bioinformatics. 23:3024–3031. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Standal T, Borset M and Sundan A: Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol. 26:179–184. 2004.PubMed/NCBI

15 

Sanger HL, Klotz G, Riesner D, Gross HJ and Kleinschmidt AK: Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI

16 

Hsu MT and Coca-Prados M: Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 280:339–340. 1979. View Article : Google Scholar : PubMed/NCBI

17 

Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Lisignoli G, Codeluppi K, Todoerti K, Manferdini C, Piacentini A, Zini N, Grassi F, Cattini L, Piva R, Rizzoli V, et al: Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein. J Cell Physiol. 220:401–409. 2010. View Article : Google Scholar

20 

Trošt Z, Trebše R, Preželj J, Komadina R, Logar DB and Marc J: A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts. Bone. 46:72–80. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Gabusi E, Manferdini C, Grassi F, Piacentini A, Cattini L, Filardo G, Lambertini E, Piva R, Zini N, Facchini A and Lisignoli G: Extracellular calcium chronically induced human osteoblasts effects: Specific modulation of osteocalcin and collagen type XV. J Cell Physiol. 227:3151–3161. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Iaffaldano P, Ruggieri M, Viterbo RG, Mastrapasqua M and Trojano M: The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. Brain Behav Immun. 35:176–181. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Clemente N, Raineri D, Cappellano G, Boggio E, Favero F, Soluri MF, Dianzani C, Comi C, Dianzani U and Chiocchetti A: Osteopontin bridging innate and adaptive immunity in autoimmune diseases. J Immunol Res. 2016:76754372016. View Article : Google Scholar : PubMed/NCBI

24 

Standal T, Borset M and Sundan A: Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol. 26:179–184. 2004.PubMed/NCBI

25 

Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF and Yeatman TJ: Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res. 10:184–190. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL and Young RA: Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun. 67:4223–4230. 1999. View Article : Google Scholar : PubMed/NCBI

27 

Reinholt FP, Hultenby K, Oldberg A and Heinegård D: Osteopontin-a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA. 87:4473–4475. 1990. View Article : Google Scholar : PubMed/NCBI

28 

Lenton S, Seydel T, Nylander T, Holt C, Härtlein M, Teixeira S and Zaccai G: Dynamic footprint of sequestration in the molecular fluctuations of osteopontin. J R Soc Interf. 12:5062015. View Article : Google Scholar

29 

Schwarz F, Golubovic V, Becker K and Mihatovic I: Extracted tooth roots used for lateral alveolar ridge augmentation: A proof-of-concept study. J Clin Periodontol. 43:345–353. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Schwarz F, Schmucker A and Becker J: Initial case report of an extracted tooth root used for lateral alveolar ridge augmentation. J Clin Periodontol. 43:985–989. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Liu J, Liu T, Wang X and He A: Circles reshaping the RNA world: From waste to treasure. Mol Cancer. 16:582017. View Article : Google Scholar : PubMed/NCBI

32 

Hansen TB, Kjems J and Damgaard CK: Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Wang F, Nazarali AJ and Ji S: Circular RNAs as potential biomarkers for cancer diagnosis and therapy. Am J Cancer Res. 6:1167–1176. 2016.PubMed/NCBI

34 

Peng L, Yuan XQ and Li GC: The emerging landscape of circular RNA ciRS-7 in cancer (Review). Oncol Rep. 33:2669–2674. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Liu Q, Zhang X, Hu X, Dai L, Fu X, Zhang J and Ao Y: Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human cartilage degradation. Sci Rep. 6:225722016. View Article : Google Scholar : PubMed/NCBI

36 

Zheng Y, Li X, Huang Y, Jia L and Li W: The circular RNA landscape of periodontal ligament stem cells during osteogenesis. J Periodontol. 88:906–914. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Huang X, Cen X, Zhang B, Liao Y, Zhu G, Liu J and Zhao Z: Prospect of circular RNA in osteogenesis: A novel orchestrator of signaling pathways. J Cell Physiol. 234:21450–21459. 2019. View Article : Google Scholar : PubMed/NCBI

38 

Yu X and Li Z, Wan Q, Cheng X, Zhang J, Pathak JL and Li Z: Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing. Biol Chem. 399:1313–1323. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Lee SH, Park Y, Song M, Srikanth S, Kim S, Kang MK, Gwack Y, Park NH, Kim RH and Shin KH: Orai1 mediates osteogenic differentiation via BMP signaling pathway in bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 473:1309–1314. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Cotter EJ, Ip HS, Powderly WG and Doran PP: Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation. BMC Musculoskelet Disord. 9:332008. View Article : Google Scholar : PubMed/NCBI

41 

Li X, Zheng Y, Zheng Y, Huang Y, Zhang Y, Jia L and Li W: Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway. Stem Cell Res Ther. 9:2322018. View Article : Google Scholar : PubMed/NCBI

42 

Qian DY, Yan GB, Bai B, Chen Y, Zhang SJ, Yao YC and Xia H: Differential circRNA expression profiles during the BMP2-induced osteogenic differentiation of MC3T3-E1 cells. Biomed Pharmacother. 90:492–499. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu J, Ren W, Zheng Z, Huang Z, Liang T, Li F, Shi Z, Jiang Q, Yang X, Guo L, Guo L, et al: Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1. Mol Med Rep 22: 1737-1746, 2020.
APA
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F. ... Guo, L. (2020). Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1. Molecular Medicine Reports, 22, 1737-1746. https://doi.org/10.3892/mmr.2020.11264
MLA
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F., Shi, Z., Jiang, Q., Yang, X., Guo, L."Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1". Molecular Medicine Reports 22.3 (2020): 1737-1746.
Chicago
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F., Shi, Z., Jiang, Q., Yang, X., Guo, L."Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1". Molecular Medicine Reports 22, no. 3 (2020): 1737-1746. https://doi.org/10.3892/mmr.2020.11264
Copy and paste a formatted citation
x
Spandidos Publications style
Wu J, Ren W, Zheng Z, Huang Z, Liang T, Li F, Shi Z, Jiang Q, Yang X, Guo L, Guo L, et al: Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1. Mol Med Rep 22: 1737-1746, 2020.
APA
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F. ... Guo, L. (2020). Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1. Molecular Medicine Reports, 22, 1737-1746. https://doi.org/10.3892/mmr.2020.11264
MLA
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F., Shi, Z., Jiang, Q., Yang, X., Guo, L."Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1". Molecular Medicine Reports 22.3 (2020): 1737-1746.
Chicago
Wu, J., Ren, W., Zheng, Z., Huang, Z., Liang, T., Li, F., Shi, Z., Jiang, Q., Yang, X., Guo, L."Mmu_circ_003795 regulates osteoblast differentiation and mineralization in MC3T3‑E1 and MDPC23 by targeting COL15A1". Molecular Medicine Reports 22, no. 3 (2020): 1737-1746. https://doi.org/10.3892/mmr.2020.11264
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team